Corvus Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
CRVS Corvus Pharmaceuticals Inc
BE Bloom Energy Corp
UUUU Energy Fuels Inc
SAVA Cassava Sciences Inc
RAMP Liveramp Holdings Inc
TRUL Trulite Inc
SNA Snap-On Inc
QYLD Global X NASDAQ 100 Covered Call ETF
DWSN Dawson Geophysical Co
JNJ Johnson & Johnson
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which is engaged in the development and commercialization of precisely targeted oncology therapies. The Company develops drugs and antibodies that target the critical cellular elements of the immune system. The Company's lead product candidate is CPI-006, a potent humanized monoclonal antibody that is designed to react with a specific site on CD73. Its next product candidate, CPI-818, is a selective, covalent inhibitor of ITK. CPI-818 is designed to inhibit the proliferation of certain malignant T-cells. Its third product candidate, Ciforadenant is an oral, small molecule antagonist of the A2A receptor for adenosine. Its product candidate pipeline includes CPI-006, B-Cell Activating anti-CD73 antibody; CPI-818, ITK Inhibitor, Ciforadenant Adenosine A2A Receptor Antagonist; CPI-182, Anti-CXCR2 Antibody designed to block inflammation and Myeloid Suppression; and CPI-935, Adenosine A2B Receptor Antagonist.

Price
Delayed
$4.51
Day's Change
0.04 (0.89%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.63
Day's Low
4.35
Volume
(Light)

Today's volume of 298,290 shares is on pace to be much lighter than CRVS's 10-day average volume of 1,210,716 shares.

298,290
  • Prev Close
    4.47
  • Today's Open
    4.47
  • Day's Range
    4.35-4.63
  • Avg Vol (10-day)
    1.2M
  • Last (time)
    3:10p ET 10/25/21
  • Last (size)
    100
  • 52-Wk Range
    1.86 - 9.54
    LowHigh
  • (08/20/21 - 09/21/21)
    142.47%
  • 119.1%
  • Market Cap
    191.1M
  • Shares Outstanding
    42.4M
  • -0.02
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 54.16
  • (% of float 09/30/21)
    9.03

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.